Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-01-07 @ 1:06 AM
Study NCT ID:
NCT03193060
Status:
COMPLETED
Last Update Posted:
2023-07-14
First Post:
2017-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-08
First Submit QC Date:
None
Study First Post Date:
2017-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-13
Last Update Post Date:
2023-07-14
Last Update Post Date Type:
ACTUAL